Effectiveness and Tolerability of the Intensification of Canagliflozin Dose from 100 mg to 300 mg Daily in Patients with Type 2 Diabetes in Real Life: The INTENSIFY Study

Aim: This study aimed to evaluate the effectiveness and tolerability of intensifying the dose of canagliflozin from 100 mg/day (CANA100) to 300 mg/day (CANA300) in patients with type 2 diabetes (T2DM) and suboptimal metabolic control in a real-world setting. Methods: A multicenter observational stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Gorgojo-Martinez, Juan J., Ferreira-Ocampo, Pablo José, Galdón Sanz-Pastor, Alba, Cárdenas-Salas, Jersy, Antón-Bravo, Teresa, Brito-Sanfiel, Miguel, Almodóvar-Ruiz, Francisca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10342761/
https://www.ncbi.nlm.nih.gov/pubmed/37445283
http://dx.doi.org/10.3390/jcm12134248

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10342761/
https://www.ncbi.nlm.nih.gov/pubmed/37445283
http://dx.doi.org/10.3390/jcm12134248

Ejemplares similares